Data from our laboratory showed that Icariside II dramatically inhibited the proliferation of melanoma A375 and SK-MEL-5 cells in vivo and in vitro by inhibiting the activation of the JAK-STAT3 and MAPK pathways but promoting an unsustained activation peak of the PI3K-AKT pathway [47]. Here, STAT3 is linked to melanoma.